News

Astellas Pharma and Pfizer’s Xtandi shows long-term survival in prostate cancer
Astellas Pharma (ALPMY) and Pfizer (PFE) announced longer-term follow-up results from an open-label extension of the Phase 3 ...
GSK's asthma drug wins FDA approval to treat 'smoker's lung'
The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic ...
Clinical Trials Arena on MSN23h
Astellas and Pfizer’s Xtandi combo reduces death risk in prostate cancer trial
Astellas and Pfizer have reported five-year follow-up outcomes from the open-label extension of the randomised Phase III ...
MarketWatch15h
S&P 500 Pharmaceuticals Industry Index
IPC Indice de Precios Y Cotizaciones 57,987.14 27.42 0.05% ...